Journal: Cell transplantation
Article Title: Bone Marrow Stromal Cells Combined with Sodium Ferulate and n-butylidenephthalide Promote the Effect of Therapeutic Angiogenesis via Advancing Astrocyte-Derived Trophic Factors After Ischemic Stroke.
PMID/MRN: 27772541
Publication Date: 2016-Oct-21
Abstract:
Being a potential candidate for stroke treatment, bone marrow stromal cells (BMSCs) have been demonstrated to be able to enhance angiogenesis and proliferation of reactive astrocytes which subsequently lead to the amelioration of neurological injury. Increasing evidences further indicate combined BMSCs with certain agent such as simvastatin may have improved therapeutic effect. Sodium Ferulate (SF) and n-butylidenephthalide (BP), two main components of Radix Angelica Sinensis, are proved to be the important regulators of stem cells in cell migration, differentiation and pluripotency maintenance. This study aimed to investigate whether combined BMSCs with SF and BP had better therapeutic effect in the treatment of stroke, and also the underlying molecular basis. The results showed that combination treatment notably reduced neurological injury after stroke and increased the expression of astrocyte-derived vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF) and von Willebrand factor-positive vascular density in ischemic boundary zone as evaluated by immunofluorescence staining. After treatment of BMSCs plus SF and BP, astrocytes showed increased expression of VEGF and BDNF by up-regulating AKT/ mammalian target of rapamycin (mTOR) expression in oxygen-glucose deprived (OGD) environment. Human umbilical vein endothelial cells (HUVEC) incubated with the conditional medium (CM) derived from OGD astrocytes treated with BMSCs plus SF and BP showed significantly increased migration and tube formation compared with those incubated with the CM derived from OGD astrocytes treated with BMSC alone. These results demonstrate that combination treatment enhances the expression of astrocyte-derived VEGF and BDNF which contribute to angiogenesis after cerebral ischemia, and the underlying mechanism is associated with activation of astrocytic AKT/mTOR signaling pathway. Our study provides a potential therapeutic approach for ischemic stroke.